Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Swain

Showing results (171-180 of 222) with videos related to

Pageof 23
Sort By:
Annals of Internal Medicine|August 1, 1995
Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trialN V Bergasa, D W Alling, T L Talbot, et al.
American Journal of Hematology|February 1, 2005
A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: is it safe and useful?Jennifer L Shin, Jerome Teitel, Mark G Swain, et al.
CMAJ Open|May 17, 2020
Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: a cross-sectional studyAbdel Aziz Shaheen, Kiarash Riazi, Alexandra Medellin, et al.
ACR Open Rheumatology|November 14, 2022
Anti-Valosin-Containing Protein (VCP/p97) Autoantibodies in Inclusion Body Myositis and Other Inflammatory MyopathiesAdam Amlani, May Y Choi, Katherine A Buhler, et al.
The American Journal of Gastroenterology|May 17, 2021
Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016Christopher Ma, Alexander S Qian, Nghia H Nguyen, et al.
Inflammatory Bowel Diseases|May 20, 2022
Multimodal Brain MRI of Deep Gray Matter Changes Associated With Inflammatory Bowel DiseaseBradley G Goodyear, Faranak Heidari, Richard J M Ingram, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|May 29, 2013
Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapyKelly W Burak, Mark G Swain, Tania Santodomingo-Garzon, et al.
RMD Open|July 19, 2018
Depression as a risk factor for the development of rheumatoid arthritis: a population-based cohort studyIsabelle A Vallerand, Ryan T Lewinson, Alexandra D Frolkis, et al.
Canadian Journal of Gastroenterology & Hepatology|April 10, 2015
Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A population-based studyJack X Q Pang, Erin Ross, Meredith A Borman, et al.
The Lancet. Gastroenterology & Hepatology|July 7, 2022
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysisKiarash Riazi, Hassan Azhari, Jacob H Charette, et al.
Pageof 23

Showing results (171-180 of 222) with videos related to

Sort By:
Pageof 23
Annals of Internal Medicine|August 1, 1995
Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trialN V Bergasa, D W Alling, T L Talbot, et al.
American Journal of Hematology|February 1, 2005
A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: is it safe and useful?Jennifer L Shin, Jerome Teitel, Mark G Swain, et al.
CMAJ Open|May 17, 2020
Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: a cross-sectional studyAbdel Aziz Shaheen, Kiarash Riazi, Alexandra Medellin, et al.
ACR Open Rheumatology|November 14, 2022
Anti-Valosin-Containing Protein (VCP/p97) Autoantibodies in Inclusion Body Myositis and Other Inflammatory MyopathiesAdam Amlani, May Y Choi, Katherine A Buhler, et al.
The American Journal of Gastroenterology|May 17, 2021
Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016Christopher Ma, Alexander S Qian, Nghia H Nguyen, et al.
Inflammatory Bowel Diseases|May 20, 2022
Multimodal Brain MRI of Deep Gray Matter Changes Associated With Inflammatory Bowel DiseaseBradley G Goodyear, Faranak Heidari, Richard J M Ingram, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|May 29, 2013
Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapyKelly W Burak, Mark G Swain, Tania Santodomingo-Garzon, et al.
RMD Open|July 19, 2018
Depression as a risk factor for the development of rheumatoid arthritis: a population-based cohort studyIsabelle A Vallerand, Ryan T Lewinson, Alexandra D Frolkis, et al.
Canadian Journal of Gastroenterology & Hepatology|April 10, 2015
Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A population-based studyJack X Q Pang, Erin Ross, Meredith A Borman, et al.
The Lancet. Gastroenterology & Hepatology|July 7, 2022
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysisKiarash Riazi, Hassan Azhari, Jacob H Charette, et al.
Pageof 23